Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
In each case, a slight change in the drugs target protein prevents binding without abolishing its normal function
& Beal, M
Chemical class Small-molecule quinolinium compound Peptide status Not a peptide Primary research target Nicotinamide N-methyltransferase Common abbreviation 5A1MQ or 5-AMQ Evidence level Cell and animal research Human trials No controlled human trial identified UK approval No marketing authorisation identified Main evidence warning Mouse outcomes do not establish human results What Is 5-Amino-1MQ
Case report: add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis
US$ 29.42
US$ 25.07
US$ 27.67
US$ 25.24
US$ 24.54
US$ 23.82
US$ 21.90
US$ 23.47
US$ 25.07
